tuberculosis (TB)

See the following -

"Industry Will Not Support Open-Ended Science, So Govt Must"

Aradhna Wal | CNN-News18 | December 20, 2016

On December 11, News18 exposed how India’s clinical trials and drug discovery process is skewed towards diseases like cancer while ignoring the top killers of the country like TB, diarrhea and Kala Azar. Responding to that, Dr. Soumya Swaminathan, Director-General of the Indian Council for Medical Research (ICMR) told News18 there was a need to support indigenous research in India. In this interview to News18’s Aradhna Wal, Dr Swaminathan says India needs a 10-year vision on drug research...

Read More »

2050 Deadline For Tuberculosis

Kaniza Garari | Deccan Chronicle | August 26, 2013

It has been a challenge for the government of India to come up with a new drug to cure tuberculosis and scientists at IICT are keeping their fingers crossed as the new combination of PA824 moxifloxacin and pyrazinamide under the Open Source Drug Discovery has successfully entered phase-II of clinical trial. Read More »

A Patient In Minnesota Has Lassa Hemorrhagic Fever. (Don’t Panic.)

Maryn McKenna | Wired | April 4, 2014

News from the Minnesota Department of Public Health and the Centers for Disease Control and Prevention: A Minnesota traveler returning from Africa has been hospitalized with what the CDC confirms to be Lassa fever, a viral hemorrhagic fever that is often lumped together with Ebola hemorrhagic fever, though they are caused by different organisms. Read More »

Africa Innovations: 15 Ideas Helping To Transform A Continent

Mina Holland, Ian Tucker, et al. | The Guardian | August 25, 2012

A mobile phone database for dairy farmers and a strain of sweet potato that can help fight child blindness. These are just two of the imaginative new ideas that are tackling Africa's old problems Read More »

APJ Abdul Kalam For Open Source R&D For Medicines

Staff Writer | DNA | June 3, 2013

If the concept of ‘open source’ (universal access and contribution to a budding idea/technology via free licence) can be applied to developing software, then why not to promoting research and development into finding cure of diseases like malaria? Read More »

Award Winners Of CSIR-OSDD-VP Short Film Competition-2013

Anshu Bhardwaj | Open Source Drug Discovery | January 18, 2013

The final screening of the 23 shortlisted videos of CSIR-OSDD-VP Short Film Competition-2013 on “Need of New Drugs for TB” was successfully conducted by a national jury headed by veteran actor / director Shri Amol Palekar in Kolkata during 06-07 January 2013. Read More »

Baltimore City Health Department Partners With eMOCHA For Medication Adherence Pilot

Aditi Pai | Mobi Health News | November 3, 2014

Health app developer emocha, which stands for electronic mobile comprehensive health application, has partnered with the Baltimore City Health Department to run a pilot on medication adherence for patients with tuberculosis...

Read More »

By 2050, Superbugs Will Kill 10 Million People A Year

Gwynn Guilford | Quartz | December 23, 2014

A scourge is emerging across the rich and poor worlds alike, one that will claim 10 million lives a year by mid-century. Watch out for the “superbugs”—pathogens that even antibiotics can’t kill...

Read More »

Clinical Trials On Candidate Drug For TB Under OSDD To Begin Soon

Joseph Alexander | Pharmabiz | December 4, 2013

Putting the search for the first indigenous drug for tuberculosis on an advanced stage, the clinical trial of the candidate drug under the unique model of open source drug discovery (OSDD) programme will start soon. Read More »

CSIR, Royal Society Of Chemistry Team Up To Support OSDD Efforts: Minister

Staff Writer | Pharmabiz.com | August 9, 2013

Council of Scientific and Industrial Research (CSIR)  had signed a memorandum of understanding (MoU) with Royal Society of Chemistry of London to support  drug discovery efforts through the Open Source Drug Discovery (OSDD) , the Parliament has been told. Read More »

European Inventor Armed With Lab-On-A-Chip Fights Infectious Disease And Personalizes Skin Care

Tina Shah | Tech Times | January 20, 2015

Some argue antimicrobial resistance (AMR), the ability of microbes to develop resistance to antimicrobial drugs, is a growing threat. Others say superbugs are already here, citing the increase in strains of antibiotic-resistant tuberculosis worldwide and the spread of staph infections...

Read More »

Feeding A Disease With Fake Drugs

Roger Bate | New York Times | February 5, 2013

Thanks to billions of dollars spent on diagnosis and treatment [for tuberculosis] over the past decade, deaths and infections are slowly declining. Yet a disturbing phenomenon has emerged that could not only reverse any gains we’ve made, but also encourage the spread of a newly resistant form of the disease. Read More »

Fund Crunch Hits Indian Drug Trial

Jacob Koshy | The Hindu | February 27, 2016

Three years after the Council of Scientific and Industrial Research (CSIR) said it would conduct a drug trial to test a novel drug-regimen for tuberculosis (TB), lack of funds is throttling the project, several officials involved with the project told The Hindu on condition of anonymity. “The project is in the ICU (intensive care unit),” said an officer, “and unless the CSIR takes a decision it is likely to die.”...

Read More »

Funding Crunch Hits Neglected Diseases Plan

Staff Writer | SciDev.Net | April 29, 2014

The Open Source Drug Discovery (OSDD) programme — a global collaborative initiative supported by the Indian government to find affordable treatment for neglected tropical diseases — has suffered a temporary setback due to a funds crunch caused by tardy submission of funding estimates. Read More »

Funds Crunch Hits India's Drug Development Project

Joe C. Mathew | Business World | April 5, 2014

Lack of funds is threatening the smooth progress of India’s unique Open Source Drug Discovery (OSDD) project, a first of its kind attempt to develop drugs for neglected diseases, when it is entering a crucial phase of research. Prime Minister Manmohan Singh had in February announced that OSDD, the pet project of the Council of Scientific and Industrial Research (CSIR), had identified a lead (potential drug candidate) for tuberculosis (TB).  

Read More »